Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat

de Jongh, 2003, Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients, Br J Cancer, 88, 1199, 10.1038/sj.bjc.6600884 Dobyan, 1980, Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations, J Pharmacol Exp Ther, 213, 551 Ichimura, 2004, Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury, Am J Physiol Renal Physiol, 286, F552, 10.1152/ajprenal.00285.2002 Thadhani, 1996, Acute renal failure, N Engl J Med, 334, 1448, 10.1056/NEJM199605303342207 Safirstein, 1984, Uptake and metabolism of cisplatin by rat kidney, Kidney Int, 25, 753, 10.1038/ki.1984.86 Okuda, 1999, Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells: role of basolateral membrane transport, Toxicol Lett, 106, 229, 10.1016/S0378-4274(99)00071-5 Ludwig, 2004, Nephrotoxicity of platinum complexes is related to basolateral organic cation transport, Kidney Int, 66, 196, 10.1111/j.1523-1755.2004.00720.x Motohashi, 2002, Gene expression levels and immunolocalization of organic ion transporters in the human kidney, J Am Soc Nephrol, 13, 866, 10.1681/ASN.V134866 Inui, 2000, Cellular and molecular aspects of drug transport in the kidney, Kidney Int, 58, 944, 10.1046/j.1523-1755.2000.00251.x Okuda, 1996, cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2, Biochem Biophys Res Commun, 224, 500, 10.1006/bbrc.1996.1056 Urakami, 2001, Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules, Pharm Res, 18, 1528, 10.1023/A:1013070128668 Sugawara-Yokoo, 2000, Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney proximal tubules, Histochem Cell Biol, 114, 175, 10.1007/s004180000186 Urakami, 1998, Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs, J Pharmacol Exp Ther, 287, 800 Urakami, 2004, Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney, Pharm Res, 21, 976, 10.1023/B:PHAM.0000029286.45788.ad Okuda, 1999, Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes, Biochim Biophys Acta, 1417, 224, 10.1016/S0005-2736(99)00005-X Ito, 1999, Distribution characteristics of levofloxacin and grepafloxacin in rat kidney, Pharm Res, 16, 534, 10.1023/A:1018871029244 Masuda, 1997, mRNA distribution and membrane localization of the OAT-K1 organic anion transporter in rat renal tubules, FEBS Lett, 407, 127, 10.1016/S0014-5793(97)00314-1 Urakami, 1999, Gender differences in expression of organic cation transporter OCT2 in rat kidney, FEBS Lett, 461, 339, 10.1016/S0014-5793(99)01491-X Horiba, 2004, Gene expression variance based on random sequencing in rat remnant kidney, Kidney Int, 66, 29, 10.1111/j.1523-1755.2004.00704.x Endo, 2000, Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line, Toxicology, 146, 187, 10.1016/S0300-483X(00)00176-1 Goldstein, 1983, The nephrotoxicity of cisplatin, Life Sci, 32, 685, 10.1016/0024-3205(83)90299-0 Leibbrandt, 1995, Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells, Kidney Int, 48, 761, 10.1038/ki.1995.348 Zhang, 1993, Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices, Biochem Pharmacol, 45, 2215, 10.1016/0006-2952(93)90192-Y Wang, 2005, Cellular processing of platinum anticancer drugs, Nat Rev Drug Discov, 4, 307, 10.1038/nrd1691 Ishida, 2002, Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals, Proc Natl Acad Sci USA, 99, 14298, 10.1073/pnas.162491399 Komatsu, 2000, Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance, Cancer Res, 60, 1312 Miyashita, 2003, Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin, Oral Oncol, 39, 157, 10.1016/S1368-8375(02)00038-6 Nakayama, 2004, Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy, Clin Cancer Res, 10, 2804, 10.1158/1078-0432.CCR-03-0454 Cui, 1999, Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells, Mol Pharmacol, 55, 929 Koike, 1997, A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells, Cancer Res, 57, 5475 Zhou, 1997, Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast, Proc Natl Acad Sci USA, 94, 7481, 10.1073/pnas.94.14.7481 Buchler, 1996, cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats, J Biol Chem, 271, 15091, 10.1074/jbc.271.25.15091 Petrukhin, 1994, Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions, Hum Mol Genet, 3, 1647, 10.1093/hmg/3.9.1647 Grundemann, 1994, Drug excretion mediated by a new prototype of polyspecific transporter, Nature, 372, 549, 10.1038/372549a0 Klein, 1991, Renal handling of cisplatin: interactions with organic anions and cations in the dog, Clin Invest Med, 14, 388 Chirino, 2004, Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats, BMC Pharmacol, 4, 20, 10.1186/1471-2210-4-20 Jo, 2005, MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis, Kidney Int, 67, 458, 10.1111/j.1523-1755.2005.67102.x Kishore, 2004, Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria, Kidney Int, 58, 701, 10.1046/j.1523-1755.2000.00216.x Reece, 1987, Disposition of unchanged cisplatin in patients with ovarian cancer, Clin Pharmacol Ther, 42, 320, 10.1038/clpt.1987.155 Urakami, 2000, Hormonal regulation of organic cation transporter OCT2 expression in rat kidney, FEBS Lett, 473, 73, 10.1016/S0014-5793(00)01525-8 Ji, 2002, Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy, Kidney Int, 62, 514, 10.1046/j.1523-1755.2002.00464.x